Literature DB >> 12536085

MRI findings in Tolosa-Hunt syndrome before and after systemic corticosteroid therapy.

Sinan Cakirer1.   

Abstract

Tolosa-Hunt syndrome (THS) is characterized by painful ophthalmoplegia due to a granulomatous inflammation in the cavernous sinus. Corticosteroid therapy dramatically resolves both the clinical and radiological findings of THS. We present MRI findings of six patients with a clinical history of at least one episode of unilateral or bilateral orbital-periorbital pain, clinical findings of associated paresis of one or more of 3rd, 4th, 5th or 6th cranial nerves. All of the patients revealed an enlargement of the symptomatic cavernous sinus on magnetic resonance imaging (MRI) scans. Five patients revealed total resolution of the clinical findings within 1-8 weeks, following systemic corticosteroid treatment. One patient revealed only minor regression of clinical findings within 2 weeks after the initiation of the treatment, so the cavernous sinus lesion was reevaluated as meningioma on MRI, and the patient underwent surgical resection of the mass with resultant histopathological finding of cavernous sinus meningioma. A follow-up MRI scan was performed for five patients at the end of 8-weeks of steroid therapy. Three of these five patients showed total resolution of the cavernous sinus lesions whereas two of them revealed a partial regression of the cavernous sinus lesions. MRI findings before and after systemic corticosteroid therapy are important diagnostic criteria to put the definitive diagnosis of THS and to differentiate it from other cavernous sinus lesions that simulate THS both clinically and radiologically.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12536085     DOI: 10.1016/s0720-048x(02)00012-8

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  16 in total

1.  Dynamic enhancement features of cavernous sinus cavernous hemangiomas on conventional contrast-enhanced MR imaging.

Authors:  Y Jinhu; D Jianping; L Xin; Z Yuanli
Journal:  AJNR Am J Neuroradiol       Date:  2007-12-07       Impact factor: 3.825

Review 2.  An approach to the patient with painful ophthalmoplegia, with a focus on Tolosa-Hunt syndrome.

Authors:  Jonathan P Gladstone
Journal:  Curr Pain Headache Rep       Date:  2007-08

3.  Painful Ophthalmoplegia Following Dental Procedure.

Authors:  Ilke Bahceci Simsek; Ozge Yabas Kiziloglu; Sule Ziylan
Journal:  Neuroophthalmology       Date:  2013-07-25

4.  Added value of contrast-enhanced CISS imaging in relation to conventional MR images for the evaluation of intracavernous cranial nerve lesions.

Authors:  Akiko Yagi; Noriko Sato; Ayako Takahashi; Hideo Morita; Makoto Amanuma; Keigo Endo; K Takeuchi
Journal:  Neuroradiology       Date:  2010-04-10       Impact factor: 2.804

Review 5.  Inflammatory Disorders of the Skull Base: a Review.

Authors:  Pria Anand; Bart K Chwalisz
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

6.  The evaluation of ICHD-3 beta diagnostic criteria for Tolosa-Hunt syndrome: a study of 22 cases of Tolosa-Hunt syndrome.

Authors:  Rui Hao; Yanjin He; Hong Zhang; Wei Zhang; Xiaorong Li; Yifeng Ke
Journal:  Neurol Sci       Date:  2015-03-04       Impact factor: 3.307

Review 7.  Tolosa-Hunt Syndrome: A Review of Diagnostic Criteria and Unresolved Issues.

Authors:  Paromita Dutta; Kamlesh Anand
Journal:  J Curr Ophthalmol       Date:  2021-07-05

Review 8.  Painful ophthalmoplegia: overview with a focus on Tolosa-Hunt syndrome.

Authors:  Jonathan P Gladstone; David W Dodick
Journal:  Curr Pain Headache Rep       Date:  2004-08

9.  Double Down on Double Vision: An Unusual Case of Painful Diplopia.

Authors:  John Oghene; Sri Harsha Boppana; Pooja Reddy; Bryce D Beutler; Deepan Dalal
Journal:  Cureus       Date:  2021-12-30

10.  Rapid-developed primary malignant myoepithelioma in the cavernous sinus: a case report.

Authors:  Yuan Hong; Song-Xue Guo; Sheng Chen; Damon Klebe; Jian-Min Zhang; Qun Wu
Journal:  BMC Neurol       Date:  2013-05-04       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.